This compound is a salt form of an active pharmaceutical ingredient impurity, specifically the hemifumarate salt of a bis-substituted aliskiren analog. It is characterized as a highly flexible molecule with multiple hydrogen bond donors and acceptors, consistent with a pharmaceutical impurity standard.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Telaglenastat
pharmaceutical raw material
Barbital sodium
pharmaceutical raw material
Trihexyphenidyl
pharmaceutical raw material
Piperazine citrate
pharmaceutical raw material
bis((2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[hydroxy-[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acid
PDYNUEBDJNAXLX-RSHGANEQSA-N
CC(C)[C@H](C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N)C(C1=CC(=C(C=C1)OC)OCCCOC)O.CC(C)[C@H](C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N)C(C1=CC(=C(C=C1)OC)OCCCOC)O.C(=C/C(=O)O)\C(=O)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.